Transcriptional activation of urokinase by the Kruppel-like factor Zf9/COPEB activates latent TGF-β1 in vascular endothelial cells

Blood

Volumn 95, Issue 4, 2000, Pages 1309-1316

  Kojima, Soichi ^a   Hayashi, Shinichi ^b   Shimokado, Kentaro ^b   Suzuki, Yasuhiro ^b   Shimada, Jun ^b   Crippa, Massimo P ^b   Friedman, Scott L ^b  

^a RIKEN TSUKUBA INSTITUTE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN ZF9 COPEB; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; CATTLE; CONTROLLED STUDY; DROSOPHILA; ENDOTHELIUM CELL; FIBRINOLYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN INDUCTION; RAT; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; AORTA; BASE SEQUENCE; BINDING SITES; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CATTLE; CELL LINE; CELL MEMBRANE; CELLS, CULTURED; DROSOPHILA MELANOGASTER; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MUTAGENESIS, SITE-DIRECTED; PLASMIN; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; RATS; RECOMBINANT PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; URINARY PLASMINOGEN ACTIVATOR;

EID: 0034651894     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Olaso E, Friedman SL. Molecular regulation of hepatic fibrogenesis. J Hepatol. 1998;29:836.
2. Martin P. Wound healing-aiming for perfect skin regeneration. Science. 1997;276:75.
3. Alcolado R, Arthur MJP, Iredale JP. Pathogenesis of liver fibrosis. Clin Sci. 1997;92:103.
4. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med. 1994;331: 1286.
5. Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276:60.
6. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115.
7. Tkachuk V, Stepanova V, Little PJ, Bobik A. Regulation and role of urokinase plasminogen activator in vascular remodelling. Clin Exp Pharmacol Physiol. 1996;23:759.
8. Reidy MA, Irvin C, Lindner V. Migration of arterial wall cells: expression of plasminogen activators and inhibitors in injured rat arteries. Circ Res. 1996;78:405.
9. Carmeliet P, Moons L, Lijnen R, et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet. 1997;17:439.
10. Bachmann F. The plasminogen-plasmin enzyme system. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd ed. Philadelphia, PA: JB Lippincott: 1994:1592.
11. Ellis V, Danø K. u-Plasminogen activator. In: Barrett AJ, Rawlings ND, Woessner JF, eds. Handbook of Proteolytic Enzymes. London, UK: Academic Press; 1998:177.
12. Carmeliet P, Moons L, Herbert J-M, et al. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Cir Res. 1997;81:829.
13. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 1993; 73:161.
14. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 1997;91:439.
15. Herbert JM, Carmeliet P. Involvement of u-PA in the anti-apoptotic activity of TGFβ for vascular smooth muscle cells. FEBS Lett. 1997;413:401.
16. Mazzieri R, Masiero L, Zanerta L, et al. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants, EMBO J. 1997; 16:2319.
17. Flaumenhaft R, Kojima S, Abe M, Rifkin, DB. Activation of latent transforming growth factor β. Adv Pharmacol. 1993;24:51.
18. Brauer PR, Yee JA. Cranial neural crest cells synthesize and secrete a latent form of transforming growth factor β that can be activated by neural crest cell proteolysis. Dev Biol. 1993;155:281.
19. Yee JA, Van L, Dominguez JC, Allan EH, Martin TJ. Plasminogen-dependent activation of latent transforming growth factor beta (TGF β) by growing cultures of osteoblast-like cells. J Cell Physiol. 1993;157:528.
20. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice. Nature. 1994;370:460.
21. Nunes I, Shapiro RL, Rifkin DB. Characterization of latent TGF-β activation by murine peritoneal macrophages. J Immunol. 1995;155:1450.
22. Khalil N, Corne S, Whitman C, Yacyshyn H. Plasmin regulates the activation of cell-associated latent TGF-β 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol. 1996;15:252.
23. Nunes I, Gleizes PE, Metz CN, Rifkin DB. Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β. J Cell Biol. 1997;136:1151.
24. Cai J, Zheng T, Lotz M, Zhang Y, Masood R, Gill P. Glucocorticoids induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor-β. Blood 1997;89:1491.
25. Okuno M, Moriwaki H, Imai S, et al. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-β in liver stellate cells. Hepatology. 1997;26:913.
26. Soubt MK, Marksitzer R, Menoud PA, Nagamine Y. Role of tissue-specific transcription factor LFB3 in a cyclic AMP-responsive enhancer of the urokinase-type plasminogen activator gene in LLC-PK1 cells. Mol Cell Biol. 1998;18:4698.
27. Iwasaka C, Tanaka K, Abe M, Sato Y. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol. 1996;169:522.
28. De Cesare D, Palazzolo M, Blasi F. Functional characterization of COM, a DNA region required for cooperation between AP-1 sites in urokinase gene transcription. Oncogene. 1996;13:2551.
29. Berthelsen J, Vandekerkhove J, Blasi F. Purification and characterization of UEF3, a novel factor involved in the regulation of the urokinase and other AP-1 controlled promoters. J Biol Chem. 1996;271:3822.
30. De Cesare D, Palazzolo M, Berthelsen J, Blasi F. Characterization of UEF-4, a DNA-binding protein required for transcriptional synergism between two AP-1 sites in the human urokinase enhancer. J Biol Chem. 1997;272:23,921.
31. Miralles F, Parra M, Caelles C, Nagamine Y, Félez J, Mun̄oz-Cánoves P. UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: requirement of an AP1 enhancer element. Mol Cell Biol. 1998;18:4537.
32. Reuning U, Wilhelm O, Nishiguchi T, et al. Inhibition of NF-κB-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1. Nucleic Acids Res. 1995;23. 3887.
33. Khachigian LM, Lindner V, Williams AJ, Collins T. Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science. 1996; 271:1427.
34. Kadonaga JT, Courey AJ, Ladika J, Tjian R. Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science. 1988;242: 1566.
35. Courey AJ, Tjian R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell. 1988; 55:887.
36. Verde P, Boast S, Franzè A, Robbiati F, Blasi F. An upstream enhancer and a negative element in the 5′ flanking region of the human urokinase plasminogen activator gene. Nucleic Acids Res. 1988;16:10,699.
37. Suzuki Y, Shimada J, Shudo K, Matsumura M, Crippa MP, Kojima S. Physical interaction between retinoic acid receptor and Sp1: mechanism for induction of urokinase by retinoic acid. Blood, 1999;93:4264.
38. Lalazar A, Wong L, Yamasaki G, Friedman SL. Early genes induced in hepatic stellate cells during wound healing. Gene. 1997;195:235
39. Ratziu V, Lalazar A, Wong L, et al. Zf9, a Krüppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc Natl Acad Sci USA. 1998;95:9500.
40. Koritschoner NP, Bocco JL, Panzetta-Dutari GM, Dumur CI, Flury A, Patrito LC. A novel human zinc finger protein that interacts with the core promoter element of a TATA box-less gene. J Biol Chem. 1997;272:9573.
41. Suzuki T, Yamamoto T, Kurabayashi M, Nagai R, Yazaki Y, Horikoshi M. Isolation and initial characterization of GBF, a novel DNA-binding zinc finger protein that binds to the GC-ricri binding sites of the HIV-1 promoter. J Biochem. 1998;124:389.
42. Sogawa K, Imataka H, Yamasaki Y, Kusume H, Abe H, Fujii-Kuriyama Y. cDNA cloning and transcriptional properties of a novel GC box-binding protein, BTEB2. Nucleic Acids Res. 1993;21: 1527.
43. Miller IJ, Bieker JJ. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Krüppel family of nuclear proteins. Mol Cell Biol. 1993;13: 2776.
44. Anderson KP, Kern CB, Crable SC, Lingrel JB. Isolation of a gene encoding a functional zinc finger protein homologous to erythroid Krüppel-like factor: identification of a new multigene family. Mol Cell Biol. 1995;15:5957.
45. Crossley M, Whitelaw E, Perkins A, Williams G, Fujiwara Y, Orkin SH. Isolation andcharacterization of the cDNAencoding BKLF/TEF-2, a major CACCC-box-binding protein in erythroid cells and selected other cells. Mol Cell Biol. 1996;16:1695.
46. Shields JM, Christy RJ, Yang VW. Identification and characterization of a gene encoding a gutenriched Krüppel-like factor expressed during growth arrest. J Biol Chem. 1996;271:20,009.
47. Garrett-Sinha LA, Eberspaecher H, Seldin MF, de Crombrugghe B. A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells. J Biol Chem. 1996;271:31,384.
48. Yet SF, McA'Nulty MM, Folta SC, et al. Human EZF, a Krüppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J Biol Chem. 1998;273:1026.
49. Tachibana I, Imoto M, Adjei PN, et al. Overexpression of the TGFβ-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest. 1997;99:2365.
50. Cook T, Gebelein B, Mesa K, Mladek A, Urrutia R. Molecular cloning and characterization of TIEG2 reveals a new subfamily of transforming growth factor-β-inducible Sp1-like zinc finger-encoding genes involved in the regulation of cell growth. J Biol Chem. 1998;273:25,929.
51. Matsumoto N, Laub F, Aldabe R, et al. Cloning the cDNA for a new human zinc finger protein defines a group of closely related Krüppel-like transcription factors. J Biol Chem. 1998;273:28,229.
52. Philipsen S, Suske G. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 1999;27:2991.
53. Kim Y, Ratziu V, Choi SG, et al. Transcriptional activation of transforming growth factor β1 and its receptors by the Krüppel-like factor Zf9/core promoter-binding protein and Sp1: potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem. 1998;273:33,750.
54. Kojima S, Muramatsu H, Amanuma H, Muramatsu T. Midkine enhances fibrinolytic activity of bovine endothelial cells. J Biol Chem. 1995;270: 9590.
55. Clowes AW, Clowes MM, Au YPT, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Cir Res. 1990;67:61.
56. Kojima S, VerNooy R, Moscatelli D, Amanuma H, RifKin DB. Lipopolysaccharide inhibits activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Physiol. 1995;163:210.
57. Soravia E, Grebe A, De Luca P, et al. A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene. Blood. 1995;86:624.
58. Johnson MR, Bruzdzinski CJ, Winograd SS, Gelehrter TD. Regulatory sequences and protein-binding sites involved in the expression of the rat plasminogen activator inhibitor-1 gene. J Biol Chem. 1992;267:12,202.
59. Kojima S, Rifkin DB. Mechanism of retinoid-induced activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Physiol. 1993;155:323.
60. Flaumenhaft R, Abe M, Mignatti P, Rifkin DB. Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: regulation of plasminogen activator activity. J Cell Biol. 1992;118:901.
61. Ratziu V, Kim SJ, Kim YS, Dang Q, Wong L, Friedman SL. A key role for Zf9 in hepatic fibrosis via its transcriptional activation of TGFβ1 and types I and II TGFβ receptor genes in rat stellate cells [abstract]. Hepatology. 1997;26:185A.
62. Crawford SE, Stellmach V, Murphy-Ullrich JE, et al. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell. 1998;93:1159.
63. Munger JS, Huang X, Kawakatsu H, et al. The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999;96:319
64. Sato Y, Tsuboi R, Lyons R, Moses H, Rifkin DB. Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol. 1990;111:757.